MetalloBio are developing novel antimicrobial leads to treat pathogenic, multi-drug resistant infections caused by both Gram-positive and Gram-negative bacteria.
| Website | http://www.metallobio.com |
| Employees | 9 (2 on RocketReach) |
| Founded | 2021 |
| Industry | Biotechnology Research |
| Keywords | New Antibiotics, Antibiotic Resistance, Infectious Disease Treatment, Antibacterial Agents, Antimicrobial Research, Bacterial Infections, Infectious Disease Research, Drug Development, Innovative Therapeutics, Lead Optimization, Pharmaceutical Research, Clinical Stage Drug Development, Drug Discovery Platform, Preclinical Development |
| Competitors | LanzaTech, Cobalt, General Motors, Chrysal International BV, CARBON CLEAN LTD, Ubiquitous Energy, Biosyntia, Sierra Energy, Air Products, Evonik +28 more (view full list) |
Looking for a particular MetalloBio employee's phone or email?
Kirsty Smitten is the CEO and co-founder of MetalloBio.
2 people are employed at MetalloBio.